Protests arise over health care denial issues, highlighting frustrations with profit-driven insurance, particularly after the assassination of UnitedHealthcare's CEO.
The role of pharmacy benefit managers (PBMs) in escalating drug costs remains largely unexamined by the public, despite their significant impact.